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Ab stra ct
In tro duc tion: Venous throm boem bo lic di sea se is one of the lea di ng cau ses of mor bi di ty and mor ta li ty in the de ve lo ped wor ld. Iden ti "  ca tion of 
he re di ta ry fac to rs of throm bop hi lia is con tri bu ti ng to a bet ter un der stan di ng of the etio lo gy and di sea se pre ven tion. The aim of this stu dy was to 
as se ss the pre va le nce of fac tor II G20210A, fac tor V Lei den, MTHFR (met hyle ne tet ra hydro fo la te re duc ta se) C677T and PAI-1 (plas mi no gen ac ti va tor 
in hi bi to r-1) 5G/4G po lymor phis ms in heal thy Croa tian sub jec ts and pa tien ts wi th throm boem bo li sm.
Ma te ria ls and met ho ds: This pros pec ti ve stu dy in clu ded 100 throm boem bo lic pa tien ts con se cu ti ve ly ad mit ted to the In ten si ve Ca re Unit, Ses tre 
Mi los r dni ce Uni ver si ty Hos pi tal and 106 heal thy sub jec ts. Ge no typi ng of fac tor II G20210A, fac tor V Lei den, MTHFR C677T and PAI-1 5G/4G po lymor-
phis ms was do ne usi ng mel ti ng cur ve ana lysis on Lig ht Cycler 1.2 ana lyzer.
Re sul ts: Hete ro zygo tes for Fac tor V Lei den po lymor phi sm we re mo re freque nt in the group of pa tien ts wi th the throm boem bo lic di sea se (16%) 
than in the con trol heal thy sub jec ts (2.9%), OR (95% CI) = 6.41 (1.81–22.8); P = 0.004. Al le le and ge no type frequen cies of ot her stu died po lymor-
phis ms did not diN er be tween ca ses and con tro ls.
Con clu sion: This stu dy con " r med the as so cia tion of fac tor V Lei den po lymor phi sm wi th the throm boem bo lic di sea se in Croa tian po pu la tion.
Key wor ds: throm bop hi lia; coa gu la tion di sor de rs; po lymor phi sm; FV Lei den; fac tor II; plas mi no gen ac ti va tor in hi bi to r-1; met hyle ne tet ra hydro fo la-
te re duc ta se
Re cei ved: De cem ber 7, 2009 Ac cep ted: Mar ch 31, 2010
In tro duc tion
Ve nous throm boem bo lic (VTE) di sea se is one of the 
lea di ng cau ses of mor ta li ty and mor bi di ty in de ve-
lo ped coun tries. The di sea se can ma ni fe st it se lf 
throu gh throm bo tic ob struc tion of ve nous system 
and usual ly oc cu rs as deep vein throm bo sis of the 
leg. Fa tal com pli ca tio ns in the fo rm of mas si ve pul-
mo na ry em bo li sm oc cur in 20% of ca ses (1).
The in ci den ce of the VTE di sea se in Cau ca sian po-
pu la tion has not chan ged du ring the pa st twen ty-
E  ve yea rs. In the whi te Ame ri can po pu la tion it oc-
cu rs in 108/100,000 peop le a year (2). The hig he st 
in ci den ce is in Af ri can po pu la tion and the lowe st 
in Ea st Asia, Alas ka and amo ng the Na ti ve Ame ri-
ca ns (3–6). Ve nous throm boem bo lic di sea se oc cu-
rs as a re su lt of in te rac tion re la ted to a se ries of ri sk 
fac to rs: acqui red, en vi ron men tal and in he ri ted fac-
to rs (7,8). The ri sk in crea ses in pro por tion to the 
num ber of ri sk fac to rs (9). Ve nous throm boem bo-
lic disea se is hig hly he ri tab le, and mul tip le co-in he-
ri ted ge ne tic ri sk fac to rs in crea se the in ci de nt risk.
The mo st com mon in he ri ted fac to rs for throm-
bop hi lia in Cau ca sia ns are fac tor V (FV) R506Q (Lei-
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den) and fac tor II (FII) G20210A (prot hrom bin) po-
lymor phis ms. The frequen cy of the FV Lei den in 
Eu ro pe va ries ac ro ss did e re nt geog rap hi cal re gio-
ns. It is the lowe st in Nor th Eu ro pe and the hig he st 
in Sou th Eu ro pe and in the Me di ter ra nean area 
(10). Pa tien ts who are car rie rs of the mu ta tion are 
mo re sus cep tib le to throm bop hi lia, es pe cial ly at a 
youn ger age. Ac ti va ted pro tein C re sis tan ce is res-
pon sib le for 30% ca ses of throm bo sis, whe reas the 
pre sen ce of mu ta tio ns in crea ses the risk of throm-
bo sis 3–7 ti mes (11,12). In the heal thy po pu la tion 
the ri sk for the de ve lop me nt of VTE is 1 per 1,000 
per year. The ri sk in car rie rs of one po lymor phic al-
le le of FV Lei den is 4–8/1,000 and for the ho mo-
zygo tes 80/1,000 per year (13).
In 1996 Poo rt and his group ha ve des cri bed the 
sin gle nuc leo ti de mu ta tion in the ge ne of prot-
hrom bin that is as so cia ted wi th an in crea sed ri sk 
for throm bo sis. It is a sin gle ba se exchan ge in whi-
ch gua ni ne rep la ces ade ni ne at the po si tion 20210 
in the re gu la to ry 3’of the ge ne that en co des this 
fac tor. The chan ge in the ge no me re sul ts in an in-
crea sed ge ne expres sion (14). In pa tien ts who are 
car rie rs of the mu ta ted al le le an in crea sed ac ti vi ty 
of prot hrom bin in plas ma was ob ser ved. Re sul ts of 
the stu dy by Mar gag lio ne shows that the frequen-
cy of this mu ta tion is hig her in the pa tie nts wi th 
the throm boem bo lic di sea se when com pa red to 
the con tro ls (8.01% com pa red to 2.29%, P < 0.001) 
and its pre sen ce in crea ses the ri sk for throm bo sis 
wi th OR (95% CI) = 3.88 (2.23–6.74) (15). The pre va-
len ce of he te ro zygo tes in the po pu la tion is 0.7–
4.0%, bei ng the mo st com mon in Eu ro pean po pu-
la tion (16). Ac cor di ng to the re sul ts of lar ge Lei den 
Trom bop hi lia Stu dy (LETS), the frequen cy of FII 
G20210A mu ta tion was hig her in the group of pa-
tien ts wi th the throm boem bo lic di sea se when com-
pa red to the heal thy po pu la tion (6.2% vs. 2.3%, re-
la ti ve ri sk = 2.8) (17).
Ac cor di ng to li te ra tu re da ta, the re la ti ve ri sk of 
throm bo sis is two ti mes hig her in pa tien ts wi th 
the prot hrom bin ge ne mu ta tion, three ti mes hig-
her in pa tien ts wi th the mu ta tion for FV Lei den 
and six ti mes hig her in patien ts who are car rie rs of 
bo th mu ta tio ns, com pa red to pa tien ts who ha ve 
the wi ld-type ge no type for bo th ge nes. The in ci-
den ce of ve nous throm boem bo li sm is lower in 
prot hrom bin mu ta tion car rie rs com pa red to FV 
mu ta tion car rie rs (18).
Be si des the abo ve men tio ned ge ne tic fac to rs, hy-
per ho mo cystei nae mia is al so as so cia ted wi th a 
sig ni E  can tly hig her ri sk of de ve lo pi ng an ear ly at-
he ros cle ro sis and ve nous throm boem bo li sm (19). 
Fro st has des cri bed the sin gle nuc leo ti de po lymor-
phi sm C677T in the co di ng re gion of the met hyle-
ne tet ra hydro fo la te re duc ta se (MTHFR) ge ne (20). 
Inci den ce of he te ro zygo tes for this po lymor phi sm 
is about 45% and the in ci den ce of homo zygo tes is 
ap proxi ma te ly 15% in the ge ne ral po pu la tion (21). 
In the car rie rs of po lymor phic al le le, the newly for-
med pro tein is ther mo la bi le, and at 37 ºC its en-
zyme ac ti vi ty is re du ced to 50%. Ma ny stu dies ha-
ve shown that car rie rs of bo th po lymor phic al le les 
ha ve mo de ra te ly in crea sed con cen tra tion of ho-
mo cystei ne. The exa ct im pa ct on the oc cur ren ce 
of ve nous throm bo sis has been un clear so far, but 
it is qui te ob vious that the pre sen ce of hyper ho-
mo cystei ne mia in crea ses the ri sk for throm bo sis 
(22). In the Lei den Throm bop hi lia Stu dy, ho mo-
cystei ne con cen tra tion abo ve the 95th per cen ti le 
sig ni E  can tly in crea sed the ri sk for throm bo sis wi th 
the OR (95% CI) = 2.5 (1.2–5.2).
The plas mi no gen ac ti va tor in hi bi to r-1 (PAI-1) pro-
mo ter 4G/5G in ser tion/deletion po lymor phi sm is 
as so cia ted wi th chan ges in plas ma con cen tra tion 
of PAI-1, bei ng 25% hig her in mu ta ted al le le car rie-
rs than in wi ld-type in di vi dua ls. Ac cor di ng to pre-
vious stu dies, the 4G al le le rep re sen ts an ad di tio-
nal ri sk fac tor for the oc cur ren ce of deep ve nous 
throm bo sis and myo car dial in far ction at a youn ger 
age in com bi na tion wi th ot her ri sk fac to rs (23,24).
Whi le re por ts on the pre va len ce of ge ne tic ri sk 
fac to rs for throm bop hi lia are nu me rous, the re are 
on ly few re por ts on this in Croa tian po pu la tion 
(25,26). It has lo ng been re por ted that pre va len ce 
of va rious ge ne tic fac to rs sig ni E  can tly did e rs ac ro-
ss did e re nt re gio ns wit hin Eu ro pe, as we ll as on 
the glo bal wor ld le vel. We ha ve the re fo re un der ta-
ken this stu dy to exa mi ne the frequen cy of FV Lei-
den, FII G20210A, MTHFR C677T and PAI-1 4G/5G 
po lymor phis ms in Croa tian pa tien ts wi th throm-
boem bo lic di sea se and to de ter mi ne whet her the-
re is a did e ren ce in po lymor phi sm frequen cy be-
tween pa tien ts wi th VTE and heal thy sub jec ts.
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Ma te ria ls and met ho ds
Pa tien ts
This pros pec ti ve stu dy was con duc ted in the pe-
riod of 2004–2005 at the In ten si ve ca re Unit of the 
De par tme nt of In ter nal Me di ci ne, Ses tre mi los r-
dni ce Uni ver si ty Hos pi tal. All pa tien ts who we re 
trea ted for ve nous throm boem bo lic di sea se we re 
con se cu ti ve ly in clu ded in the stu dy.
For the pur po se of com pa ri son, a group of 106 
heal thy in di vi dua ls, rec rui ted at the pri ma ry heal th 
ca re gi ver, was al so in clu ded in this stu dy. The 
heal thy in di vi dua ls had no per so nal or fa mi ly re co-
rd of throm boem bo lic di sea se and we re free of 
any syste mic, car dio vas cu lar, ma lig na nt and in-
o am ma to ry di sea se at the ti me when they con sen-
ted to en ter the stu dy.
In all pa tien ts the diag no sis of deep ve nous throm-
bo sis was con E r med by leg dup lex scan blood ves-
se ls ul tra sou nd (ATL HDI-500, So lin gen, Ger ma ny). 
The diag no sis of pul mo na ry em bo li sm was con E r-
med ac cor di ng to Gui de li nes for the Ma na ge me nt 
of Sus pec ted Acu te Pul mo na ry Em bo li sm (27). Pa-
tien ts we re trea ted and fol lowed ac cor di ng to the 
stan da rd pro to col (28).
De mog rap hic cha rac te ris ti cs (age, gen der) and 
known ri sk fac to rs for the throm boem bo lic di sea-
se we re col lec ted for all par ti ci pan ts of the stu dy.
All ca ses and con tro ls we re ful ly in for med about 
the stu dy pro to col by the main in ves ti ga tor and 
ha ve con sen ted to par ti ci pa te in the stu dy by sig-
ni ng the writ ten con se nt. The stu dy was appro ved 
by the Et hi cs Com mit tee of the hos pi tal.
Met ho ds
The DNA was iso la ted from EDTA an ti coa gu la ted 
who le blood (Va cu tai ner Bec ton Dic kin son, Mey-
lan Ce dex, Fran ce) usi ng the com mer cial QIAa mp 
DNA Blood Mi ni Kit (250) (QIAGEN GmbH, Hil den, 
Ger ma ny). The FV Lei den, Fac to r II G20210A, MTH-
FR C677T and PAI-1 4G/5G po lymor phis ms we re 
ge no typed by real ti me PCR and mel ti ng cur ve 
ana lysis usi ng Lig ht Cycler 1.2 (Roc he Diag nos ti cs, 
Man nheim, Ger ma ny).
Sta tis ti cal ana lysis
The da ta we re pre sen ted as coun ts and per cen ta-
ges. Did e ren ces be tween grou ps we re tes ted wi th 
Chi-squa re te st. The Fis cher exa ct te st was used for 
tho se grou ps whe re re la ti ve frequen cies we re low. 
Age did e ren ces be tween grou ps we re as ses sed 
usi ng t-te st. Sta tis ti cal sig ni E  can ce was set at 0.05. 
All grou ps we re tes ted for Har dy-Wein be rg equi li-
b rium. Sta tis ti cal ana lysis was per for med by usi ng 
the Med Ca lc R 10.1.1.0 sta tis ti cal sof twa re (Fran ck 
Schoo nja ns, Ma ria ker ke, Bel gium).
Re sul ts
This stu dy in clu ded 100 pa tien ts wi th the ve nous 
throm boem bo lic di sea se and 106 heal thy in di vi-
dua ls. De mog rap hic cha rac te ris ti cs are sum ma ri-
zed in Tab le 1.
Out of four tes ted po lymor phis ms, on ly the FV Lei-
den po lymor phi sm showed to be sig ni fi can tly 
asso cia ted wi th ve nous throm boem bo lic di sea se 
wi th an od ds ra tio OR (95% CI) = 6.41 (1.81–22.76); 
P = 0.004. When pa tien ts wi th ot her known ri sk 
fac to rs we re exclu ded from the pa tie nt group, the 
ri sk for the oc cur ren ce of throm boem bo lic di sea se 
due to the iso la ted FV Lei den ge ne tic po lymor phi-
sm (N = 44) was even hig her wi th OR (95% CI) = 
9.81 (2.69–35.79); P < 0.001.





fe ma le N, (%) 45 (45%) 67 (63%) 0.013
age 51 ± 21 68 ± 8 < 0.001
age ne sia of VCI 2 /
he roin ad dic ts 3 /
preg nan cy 4 /
trau ma 5 /
es tro ge ns 6 /
can cer 15 /
obe si ty 23 /
VCI – lower ve na ca va
TAB LE 1. Demog rap hic cha rac te ris ti cs of ca ses and con tro ls
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Al le le and ge no type frequen cies of F II G20210A, 
MTHFR C677T and PAI-1 4G/5G po lymor phis ms 
did not did er sig ni E  can tly be tween ca ses and con-
tro ls. Al le le and ge no type frequen cies are pre sen-
ted in Tab le 2.
Dis cus sion
We ha ve in ves ti ga ted the frequen cy of FV Lei den, 
FII, MTHFR, and PAI-1 po lymor phis ms and their as-
so cia tion wi th VTE in the Croa tian po pu la tion. The 
li mi ta tion of our stu dy was the sma ll num ber of 
pa tien ts in the sub grou ps.
Ve nous throm boem bo lic di sea se is a he re di ta ry 
com mon di sea se of the Cau ca sian po pu la tion that 
can be cau sed by a num ber of ge ne tic and en vi-
ron men tal ri sk fac to rs that en han ce the pro coa gu-
la tion ten den cy. It is im por ta nt to em pha si ze that 
the pre sen ce of po lymor phic al le le on ly by it se lf is 
not sur   cie nt for the oc cur ren ce of throm bo sis. All 
stu dies con fo rm to the mul ti fac to rial etio lo gy of 
the di sea se. The ri sk of the throm boem bo lic di sea-
se in crea ses in pro por tion to the num ber of ri sk 
fac to rs (29).
Fac tor V Lei den, whi ch ren de rs FV re sis ta nt to ac ti-
va ted pro tein C (APC) deg ra da tion, is the mo st 
com mon in he ri ted ri sk fac tor in Cau ca sia ns, wi th 
an ave ra ge pre va len ce in heal thy po pu la tion of 
about 4.4% (2–15%), about 18% in pa tien ts wi th 
the throm boem bo lic di sea se and about 40% in fa-
mi lies wi th his to ry of throm bop hi lia (30,31). The 
evo lu tio na ry ori gin of the mu ta tion was fou nd in 
the cen tral pa rt of Eu ro pe in the Neo lit hic Age. The 
pre va len ce in crea ses from We st to Ea st Eu ro pe 
and dec rea ses from sou th to nor th of Eu ro pe. Fac-
tor V Lei den is ra re ly fou nd in Af ri can, Aus tra lian 





Fac tor II wi ld type G/G 96 (96%) 94 (94%)
0.65 (0.17–2.39) 0.519he te ro zygous G/A 4 (4%) 6 (6%)
ho mo zygous A/A 0 0
alel le G 196 (98%) 194 (97%)
0.66 (0.18–2.37) 0.525
alel le A 4 (2%) 6 (3%)
Fac tor V wi ld type G/G 84 (84%) 101 (97.1%)
6.41 (1.81–22.76) 0.004he te ro zygous G/A 16 (16%) 3 (2.9%)
ho mo zygous A/A 0 0
alel le G 184 (92%) 205 (98.6%)
5.94 (1.70–20.72) 0.005
alel le A 16 (8%) 3 (1.4%)
PAI-1 wi ld type 5G/5G 17 (17%) 17 (16%)
1.06 (0.51–2.21) 0.876he te ro zygous 4G/5G 52 (52%) 55 (52%)
ho mo zygous 4G/4G 31 (31%) 33 (32%)
alel le 5G 86 (43%) 89 (42%)
1.03 (0.69–1.51) 0.899
alel le 4G 114 (57%) 121 (58%)
MTHFR wi ld type C/C 46 (46%) 37 (36%)
0.65 (0.37–1.14) 0.130he te ro zygous C/T 45 (45%) 59 (57%)
ho mo zygous T/T 9 (9%) 8 (7%)
alel le C 137 (68%) 133 (64%)
1.23 (0.81–1.85) 0.331
alel le T 63 (32%) 75 (36%)
* For wi ld-type vs. he te ro zygous + ho mo zygous
TAB LE 2. Al le le and ge no type frequen cies in pa tien ts and con tro ls
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and Sou th Asian po pu la tion, whi le in Asia Mi nor 
its frequen cy is on ly 0.7%, whi ch par tly explai ns 
the fa ct that the in ci den ce of throm bo sis in the se 
coun tries is low. It is al so ve ry ra re in Fren ch po pu-
la tion Ba sques (10,32). In our stu dy, the frequen cy 
of the he te ro zygous for FV Lei den po lymor phi sm 
in the con trol heal thy sub jec ts is 2.9%, whi le it is 
hig her in the group of pa tien ts wi th throm boem-
bo lic di sea se (16%). The preva len ce of fac tor V Lei-
den and prot hrom bin G20210A has al rea dy been 
des cri bed for Croa tian po pu la tion in the stu dy by 
Co hen and col la bo ra to rs in 2001 (25). A slig htly 
hig her frequen cy of mu ta tio ns for fac tor V and 
prot hrom bin G20210A (21%, 8%) in the 160 Croa-
tian pa tien ts wi th the VTE was ob ser ved. Althou gh 
the pre va len ce of mu ta tio ns amo ng our pa tien ts is 
lower, our re sul ts con cur wi th pre vious ly re por ted 
pre va len ce for Cau cau sian po pu la tio ns.
The se co nd mo st im por ta nt in he ri ted prot hrom-
bo tic ri sk fac tor, FII G20210A po lymor phi sm is pre-
se nt in Cau ca sian po pu la tion wi th the frequen cy 
of 0.7 to 4%, wi th an ave ra ge about 2%. The pre va-
len ce in the Me di ter ra nean area ran ges arou nd 
3.0% (95% CI = 2.3–3.7%), whi le in nor the rn Eu ro-
pe the frequen cy of mu ta tio ns in the po pu la tion is 
two ti mes smal ler (1.7% (95% CI = 1.3–2.2%)). The 
grea te st frequen cy of po lymor phi sm in the wor ld 
is fou nd in Mexi can po pu la tion, whe re the pre va-
len ce is extre me ly hi gh (13.5%) (16,33). The pre va-
len ce of this mu ta tion in the VTE pa tien ts is 8%, 
and even hig her pre va len ce (18%) is fou nd in se-
lec ted fa mi lies wi th throm bo sis (14). As for Fac tor 
V, the re we re no ho mo zygous pa tien ts for FII 
G20210A in our stu dy. In our in ves ti ga ted grou ps 
the re we re 4% VTE pa tien ts and 6% heal thy con-
tro ls he te ro zygous for this po lymor phi sm. The sta-
tis ti cal ana lysis has shown no sig ni E  ca nt did e ren-
ce in the pre va len ce of po lymor phis ms be tween 
grou ps whi ch does not cor res po nd to li te ra tu re 
da ta. The va lues on the frequen cy of FII G20210A 
po lymor phi sm in the con trol group are con sis te nt 
wi th the da ta pub lis hed in ot her stu dies Howe ver, 
it is im por ta nt to em pha si ze that a sma ll num ber 
of res pon den ts in clu ded in our stu dy is not sur  -
cie nt for ge ne ra li zi ng the da ta on the en ti re po pu-
la tion, due to the sma ll sam ple si ze and li mi ted 
power of the stu dy. That par tly explai ns the lower 
frequen cy of the fac tor II po lymor phi sm amo ng 
pa tien ts.
The po lymor phic al le le frequen cy of PAI-1 va ries 
amo ng ra ces and et hnic grou ps. The pre sen ce of 
the 4G al le le is increa sed in the whi te po pu la tion 
in re la tion to the Af ri ca ns and is as so cia ted wi th 
the throm bo tic di sea se in com bi na tion wi th ot her 
throm bop hi lia de fec ts (34). Ba sed on the pub lis-
hed da ta, the pre va len ce of the 4G al le le car rie rs in 
the Cau ca sian po pu la tion is about 76%, 50.5% of 
whi ch are he te ro zygo tes (4G/5G) and 26.3% ho-
mo zygo tes (4G/4G) (35). The pre va len ce of the po-
lymor phi sm in our stu dy (52% he te ro zygous and 
17% ho mo zygous) was iden ti cal in bo th stu died 
grou ps and is in ag ree me nt wi th the li te ra tu re da-
ta (36).
The pre va len ce of the T al le le al so va ries amo ng 
ra ces and et hnic grou ps. It is mo re com mon in 
Cau ca sia ns and Asia ns (0.30) com pa red to Af ri can 
Ame ri ca ns (0.11). The stu dies ha ve shown cer tain 
did e ren ces amo ng the Eu ro pean po pu la tio ns. The 
frequen cy of he te ro zygo tes (C/T) is the lar ge st in 
Ita ly 44%, as op po sed to No rway, whe re it is lower 
(28%). Me ta ana lysis of stu dies amo ng Eu ro pean 
po pu la tio ns has shown that the frequen cy of ho-
mo zygo tes (T/T) ran ges from 5–15% (21).
A stu dy by Lovričević et al., pub lis hed in 2004, con-
duc ted on 228 Croa tian vo lun tee rs has fou nd 
9.21% ho mo zygo tes (T/T), 44.74% he te ro zygo tes 
(C/T) for the mu ta tion and 46.05% car rie rs of the 
wi ld type (C/C). The se re sul ts are con sis te nt wi th 
the pre va len ce of mu ta tio ns in Eu ro pean po pu la-
tio ns (26). In our stu dy the sta tis ti cal ana lysis 
showed no sig ni E  ca nt did e ren ce in the in ci den ce 
of mu ta tio ns between the grou ps. The frequen cy 
of 9% ho mo zygous and 45% he te ro zygous ca ses 
amo ng pa tien ts is con sis te nt wi th the da ta from 
the li te ra tu re.
The frequen cy dis tri bu tion of exa mi ned po lymor-
phis ms (FV Leiden, MTHFR, PAI-1) is in ac cor dan ce 
wi th the E n din gs al rea dy re por ted in ot her Cau ca-
sian po pu la tio ns. On ly a slig htly lower frequen cy 
of fac tor II G20210A amo ng pa tien ts de via tes from 
tho se fac to rs re sul ts. FV Lei den and fac tor II 
G20210A ha ve been des cri bed as the mo st im por-
ta nt in he ri ted prot hrom bo tic ri sk fac to rs in re ce nt 
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li te ra tu re (11–15). MTHFR and PAI-1 con tri bu te to 
the ri sk in com bi na tion wi th ot her fac to rs (35,37). 
In our group of pa tien ts on ly FV Lei den cor res pon-
ded wi th an in creased prot hrom bo tic di sea se ri sk 
OR (95% CI) = 6.41 (1.81–22.76), es pe cial ly when 
pa tien ts wi th an en vi ron men tal ri sk fac tor we re 
exclu ded from the stu dy OR (95% CI) = 9.81 (2.69–
35.79). FII G20210, MTHFR and PAI-1 polymor phis-
ms we re not as so cia ted wi th ve nous throm boem-
bo li sm in our stu dy. A sma ll sam ple si ze and low 
frequen cy of the fac tor II he te ro zygo tes amo ng 
pa tien ts may par tial ly explain the la ck of as so cia-
tion for the fac tor II. The se re sul ts gi ve us so me 
new in for ma tion on throm bo sis re la ted ge ne tic 
po lymorphi sm in Croa tian po pu la tion. Gi ven the 
sma ll num ber of pa tien ts in clu ded by this stu dy, 
more in for ma ti ve re sul ts cou ld be ob tai ned by a 
broa der stu dy wi th a lar ger sam ple.
Con clu sion
Ba sed on our re sul ts, he rein we con clu de that on ly 
Fac tor V Lei den was sig ni E  can tly as so cia ted wi th 
throm boem bo lic di sea se in our pa tien ts. The ana-
lysis showed that the pre sen ce of ot her three stu-
died po lymor phis ms (Fac tor II G20210A, PAI-1 
5G/4G and MTHFR C677T) we re not as so cia ted 
with ve nous throm boem bo li sm in our stu dy.
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Frek ven ci ja po li mor I  za ma fak to ra II G20210A, fak to ra V Lei den, MTHFR 
C677T i PAI-1 5G/4G kod bo les ni ka s ven skom trom boem bo li jom: Hr vat sko 
is tra ži va nje pa ro va
Sa že tak
Uvod: Ven ske trom boem bo lij ske bo les ti je dan su od vo dećih uz ro ka po bo la i smr tnos ti u raz vi je nom svi je tu. Od ređiva nje nas ljed nih fak to ra 
trom bo "  li je dop ri no si bo ljem ra zu mi je va nju etio lo gi je i sprečavanju raz vo ja bo les ti. Cilj ovog is traživa nja bio je proci je ni ti pre va len ci ju po li mor-
"  za ma fak to ra II G20210A, fak to ra V Lei den, MTHFR C677T i PAI-1 5G/4G kod zdra vih is pi ta ni ka iz Hr va tske i kod bo les ni ka s trom boem bo li jom.
Ma te ri ja li i me to de: U ovo je pros pek tiv no is traživa nje bi lo uk ljučeno 100 uzas top nih bo lesni ka s trom boem bo li jom prim lje nih na Za vod za 
hit nu in ter nu me di ci nu Kli ničke bol ni ce Ses tre Mi los r dni ce i 106 zdra vih is pi ta ni ka. Ge no ti pi za ci ja fak to ra II G20210A, fak to ra V Lei den, MTHFR 
C677T i PAI-1 5G/4G načinje na je ana li zom kri vu lje ta lje nja na anali za to ru Lig ht Cycler 1.2.
Re zul ta ti: U sku pi ni obo lje lih od trom boem bo lij skih bo les ti bi lo je više he te ro zi go ta za po li mor " zam fak tor V Lei den (16%) ne go u kon trol noj 
sku pi ni (2.9%) s om je rom iz gle da (en gl. odds ra tio) OR (95% CI) = 6.41 (1.81–22.76); P = 0.004. Frek ven ci je ale la i ge no ti po va dru gih proučava nih 
po li mor "  za ma ni su se raz li ko va le iz među sku pi na.
Zak ljučak: Ovo je is traživa nje pot vr di lo po ve za no st po li mor " z ma fak to ra V Lei den s raz vo jem trom boem bo lij skih bo les ti Hr vat ske po pu la ci je.
Ključ ne ri je či: trom bo "  li ja; po re me ća ji koa gu la ci je; po li mor "  zam; FV Lei den; fak tor II; in hi bi tor plaz mi no gen ak ti va to ra-1; me ti len tet ra hid ro-
fo lat re duk ta za
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